Press releases | WebDisclosure

Basculer en Français

11294	Companies
250977	Keywords
179894	Articles
136848	Press releases

Home
Press releases

REGULATED PRESS RELEASE

published on 07/31/2025 at 07:00, 1 year 3 months ago

Safran reports its first-half 2025 results
Safran reports a record operating margin and cash generation with FY guidance raised as CEO Olivier Andriès emphasizes positive outlook. The acquisition of Collins Aerospace actuation and flight control business marks a major strategic milestone

Safran Cash Generation Operating Margin Collins Aerospace FY Guidance
PRESS RELEASE

published on 07/31/2025 at 07:00, 1 year 3 months ago

Activité et résultats du 1er semestre 2025
Netgem publie ses comptes semestriels 2025, avec une croissance des revenus récurrents et des marges brutes malgré un repli du chiffre d'affaires total, soulignant une situation financière solide et des perspectives de croissance

Croissance Revenus Récurrents Résultats Marge Brute Netgem
PRESS RELEASE

published on 07/31/2025 at 06:59, 1 year 3 months ago

AT&S shows upward trend in the first quarter
AT&S reports 14% revenue growth in Q1 2025/26, reaching € 399 million, with EBITDA margin at 17.7%. Forecasts revenue € 820 million for half-year and confirmed outlook for FY 2026/27

Revenue Growth EBITDA Margin AT&S Q1 2025/26 Outlook 2026/27
PRESS RELEASE

published on 07/31/2025 at 06:58, 1 year 3 months ago

Aperam - Second quarter 2025 results : “Delivering on Promises despite Headwinds”
Aperam S.A. reports resilient second quarter 2025 results with increased shipments and higher earnings despite challenges in Europe. CEO highlights portfolio strength and cost savings

Earnings Resilient Performance Shipments Second Quarter Results Aperam S.A.
PRESS RELEASE

published on 07/31/2025 at 06:58, 1 year 3 months ago

Aperam - Résultats du deuxième trimestre 2025 : “Engagements tenus malgré les vents contraires'
Aperam annonce des résultats solides pour le deuxième trimestre 2025 avec des chiffres en hausse malgré les défis. Les faits marquants incluent une augmentation des expéditions et de l'EBITDA

EBITDA Résultats Aperam Expeditions Deuxième Trimestre 2025
PRESS RELEASE

published on 07/31/2025 at 06:30, 1 year 3 months ago

Comet delivers strong sales growth in the first half-year; revised outlook reflects market uncertainty
Comet reports strong sales growth in H1 2025 despite market uncertainties. Revised outlook projects slower growth for second half 2025. Details in press release

Sales Growth Market Uncertainties Comet Revised Outlook H1 2025
PRESS RELEASE

published on 07/31/2025 at 06:30, 1 year 3 months ago

Avolta reports another solid set of results for the first half of 2025
Avolta reports solid H1 2025 results with +7.1% revenue growth, 9.3% CORE EBITDA margin, +28.7% EPS growth, and CHF 216m EFCF. Medium-term outlook confirmed

Revenue Growth Financial Performance EPS Growth Avolta H1 2025
PRESS RELEASE

published on 07/31/2025 at 06:30, 1 year 3 months ago

Strong performance with margin expansion in H1
Holcim Group Services Ltd reports strong performance with margin expansion in H1. Recurring EBIT up 10.8%, net sales up 1.8%. Confident FY2025 guidance post spin-off completion

Holcim Group Services Ltd Recurring EBIT Margin Expansion Spin-off Completion FY2025 Guidance
PRESS RELEASE

published on 07/31/2025 at 06:30, 1 year 3 months ago

Stabilization supported by sizeable projects
Interroll Holding AG reports stable sales and order intake growth in first half of 2025 despite macroeconomic challenges. Company focuses on innovation, regional expansion, and leadership change to drive growth momentum

Innovation Sales Growth Order Intake Interroll Holding AG Stabilization
PRESS RELEASE

published on 07/31/2025 at 06:00, 1 year 3 months ago

FDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study
FDA confirms Type B meeting with Curatis Holding AG to review Phase 3 plan for investigational biologic corticorelin, targeting Peritumoral Brain Edema. Development aims to reduce steroid use in patients

FDA Phase 3 Study Curatis Holding AG Corticorelin Type B Meeting

Accesswire

Published on 11/06/2026 at 22:15, 2 days 9 hours ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 18 hours ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 19 hours ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 19 hours ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 2 days 21 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/09/2026 at 07:10, 25 minutes ago

Hypoport delivers solid gross profit growth and an increase in EBIT in the first nine months of 2026
Published on 11/09/2026 at 07:00, 35 minutes ago

Sandoz launches new semaglutide treatment option in Brazil, expanding patient access to GLP-1 medicine in key global market
Published on 11/09/2026 at 07:00, 35 minutes ago

Cicor receives awards for two major defence programmes
Published on 11/09/2026 at 01:55, 5 hours 40 minutes ago

EQS-Adhoc: NEXTDC Limited: Response to Statement by Goodman Group & Digital Realty
Published on 11/08/2026 at 12:10, 19 hours 24 minutes ago

GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap

Les Echos

Published on 11/09/2026 at 07:00, 35 minutes ago

bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 35 minutes ago

BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 35 minutes ago

Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 35 minutes ago

bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 12 hours ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026

View all LES ECHOS COMFI WIRE